|
POTENTIAL FOR SEVERE AND FATAL REACTIONS INCLUDING CARDIAC ARREST, SEIZURES, RESPIRATORY FAILURE AND STATUS EPILEPTICUS ; CONCURRENT USE SHOULD BE AVOIDED OR SERUM LEVELS OF THEOPHYLLINE SHOULD BE MONITORED CAREFULLY
|
POTENTIAL FOR SEVERE AND FATAL REACTIONS INCLUDING CARDIAC ARREST, SEIZURES, RESPIRATORY FAILURE AND STATUS EPILEPTICUS ; CONCURRENT USE SHOULD BE AVOIDED OR SERUM LEVELS OF THEOPHYLLINE SHOULD BE MONITORED CAREFULLY
|
POTENTIAL FOR SEVERE AND FATAL REACTIONS INCLUDING CARDIAC ARREST, SEIZURES, RESPIRATORY FAILURE AND STATUS EPILEPTICUS ; CONCURRENT USE SHOULD BE AVOIDED OR SERUM LEVELS OF THEOPHYLLINE SHOULD BE MONITORED CAREFULLY
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
ZINC WHEN CONCURRENTLY ADMINISTERED CAN IMPAIRE ABSORPTION OF THE OTHER DRUG, SO ZINC SHOULD BE GIVEN 6 HRS BEFORE OR 2 HRS AFTER THE OTHER DRUG
|
ZINC WHEN CONCURRENTLY ADMINISTERED CAN IMPAIRE ABSORPTION OF THE OTHER DRUG, SO ZINC SHOULD BE GIVEN 6 HRS BEFORE OR 2 HRS AFTER THE OTHER DRUG
|
ZINC WHEN CONCURRENTLY ADMINISTERED CAN IMPAIRE ABSORPTION OF THE OTHER DRUG, SO ZINC SHOULD BE GIVEN 6 HRS BEFORE OR 2 HRS AFTER THE OTHER DRUG
|
ZINC WHEN CONCURRENTLY ADMINISTERED CAN IMPAIRE ABSORPTION OF THE OTHER DRUG, SO ZINC SHOULD BE GIVEN 6 HRS BEFORE OR 2 HRS AFTER THE OTHER DRUG
|
|
TRANSIENT ELEVATIONS IN SERUM CREATININE
|
DIDANOSINE SHOULD BE TAKEN 2 HRS AFTER OR 6 HRS BEFORE QUINOLONES LIKE CIPROFLOXACIN
|
CO-ADMINISTRATION OF QUINOLONES WITH ANTACIDS CONTAINING MAGNESIUM, CALCIUM, OR ALUMINUM MAY SUBSTANTIALLY INTERFERE WITH THE ABSORPTION OF QUINOLONES, IT SHOULD BE BE TAKEN 4 HOURS BEFORE OR 8 HRS. AFTER INGESTION OF ANTACIDS
|
CO-ADMINISTRATION OF QUINOLONES WITH ANTACIDS CONTAINING MAGNESIUM, CALCIUM, OR ALUMINUM MAY SUBSTANTIALLY INTERFERE WITH THE ABSORPTION OF QUINOLONES, IT SHOULD BE BE TAKEN 4 HOURS BEFORE OR 8 HRS. AFTER INGESTION OF ANTACIDS
|
CO-ADMINISTRATION OF QUINOLONES WITH ANTACIDS CONTAINING MAGNESIUM, CALCIUM, OR ALUMINUM MAY SUBSTANTIALLY INTERFERE WITH THE ABSORPTION OF QUINOLONES, IT SHOULD BE BE TAKEN 4 HOURS BEFORE OR 8 HRS. AFTER INGESTION OF ANTACIDS
|
CO-ADMINISTRATION OF QUINOLONES WITH ANTACIDS CONTAINING MAGNESIUM, CALCIUM, OR ALUMINUM MAY SUBSTANTIALLY INTERFERE WITH THE ABSORPTION OF QUINOLONES, IT SHOULD BE BE TAKEN 4 HOURS BEFORE OR 8 HRS. AFTER INGESTION OF ANTACIDS
|
QUINOLONES MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; ANTACIDS SHOULD BE GIVEN 2 HRS. AFTER OR 6 HRS. BEFORE COPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; ANTACIDS SHOULD BE GIVEN 2 HRS. AFTER OR 6 HRS. BEFORE COPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; ANTACIDS SHOULD BE GIVEN 2 HRS. AFTER OR 6 HRS. BEFORE COPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; ANTACIDS SHOULD BE GIVEN 2 HRS. AFTER OR 6 HRS. BEFORE COPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; ANTACIDS SHOULD BE GIVEN 2 HRS. AFTER OR 6 HRS. BEFORE COPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; ANTACIDS SHOULD BE GIVEN 2 HRS. AFTER OR 6 HRS. BEFORE COPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; ANTACIDS SHOULD BE GIVEN 2 HRS. AFTER OR 6 HRS. BEFORE COPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
CO-ADMINISTRATION WITH IRON-CONTAINING PREPARATIONS MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH IRON-CONTAINING PREPARATIONS MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH IRON-CONTAINING PREPARATIONS MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH IRON-CONTAINING PREPARATIONS MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
|
ENHANCED EFFECTS OF ANTICOAGULANT
|
ENHANCED EFFECTS OF ANTICOAGULANT
|
ENHANCED EFFECTS OF ANTICOAGULANT
|
ENHANCED EFFECTS OF ANTICOAGULANT
|
ENHANCED EFFECTS OF ANTICOAGULANT
|
ENHANCED EFFECTS OF ANTICOAGULANT
|
ENHANCED EFFECTS OF ANTICOAGULANT
|
CO-ADMINISTRATION WITH IRON-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE GIVEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH IRON-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE GIVEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH IRON-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE GIVEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH IRON-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE GIVEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|